<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37715620</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8175</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Echocardiography (Mount Kisco, N.Y.)</Title><ISOAbbreviation>Echocardiography</ISOAbbreviation></Journal><ArticleTitle>Spinal and bulbar muscular atrophy combined with hypertrophic cardiomyopathy and Brugada-pattern electrocardiographic changes: A case report.</ArticleTitle><Pagination><StartPage>1276</StartPage><EndPage>1279</EndPage><MedlinePgn>1276-1279</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/echo.15690</ELocationID><Abstract><AbstractText>Spinal and bulbar muscular atrophy (SBMA) is a rare X-linked recessive neurodegenerative disorder caused by the excessive expansion of cytosine-adenine-guanine repeat sequences in the androgen receptor gene encoded on the Xq11-12 chromosome. SBMA primarily affects adult males and is characterized by weakness and atrophy of the proximal limb muscles, often involving the bulbar muscles. In addition to neuromuscular deficits, nonneuronal symptoms such as hypertension, hyperlipidemia, and liver dysfunction are often observed in patients with SBMA. Previous studies have suggested that SBMA patients have been diagnosed with hypertrophic cardiomyopathy (HCM), while gene detection is lacked. Moreover, according to current reports, SBMA patients can carry Brugada syndrome or HCM respectively, while three kinds of diseases have not been reported to exist in the same patient. Here, we report the first case of a male diagnosed with SBMA combined with HCM and two types of Brugada-pattern electrocardiographic changes, with a heterozygous missense mutation in the TTN gene.</AbstractText><CopyrightInformation>&#xa9; 2023 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Tian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Geriatrics, Peking University First Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Haoyu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Peking University First Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Wenhui</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Peking University First Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Xujun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University First Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jianping</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Peking University First Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Molecular Cardiovascular Sciences of Ministry of Education, Health Science Center, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Echocardiography</MedlineTA><NlmUniqueID>8511187</NlmUniqueID><ISSNLinking>0742-2822</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011944">Receptors, Androgen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="Y">Bulbo-Spinal Atrophy, X-Linked</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011944" MajorTopicYN="N">Receptors, Androgen</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002312" MajorTopicYN="Y">Cardiomyopathy, Hypertrophic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006579" MajorTopicYN="N">Heterozygote</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brugada ECG pattern</Keyword><Keyword MajorTopicYN="N">TTN gene</Keyword><Keyword MajorTopicYN="N">hypertrophic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">spinal and bulbar muscular atrophy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>16</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>16</Day><Hour>5</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37715620</ArticleId><ArticleId IdType="doi">10.1111/echo.15690</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>La Spada AR, Wilson EM, Lubahn DB, et&#xa0;al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991;352(6330):77-79. doi:10.1038/352077a0</Citation></Reference><Reference><Citation>Araki A, Katsuno M, Suzuki K, et&#xa0;al. Brugada syndrome in spinal and bulbar muscular atrophy. Neurology. 2014;82(20):1813-1821. doi:10.1212/WNL.0000000000000434</Citation></Reference><Reference><Citation>Maron BJ, Desai MY, Nishimura RA, et&#xa0;al. Diagnosis and evaluation of hypertrophic cardiomyopathy: jACC state-of-the-art review. J Am Coll Cardiol. 2022;79(4):372-389. doi:10.1016/j.jacc.2021.12.002</Citation></Reference><Reference><Citation>Kaneko K, Igarashi S, Miyatake T, et&#xa0;al. Hypertrophic cardiomyopathy and increased number of CAG repeats in the androgen receptor gene. Am Heart J. 1993;126(1):248-249. doi:10.1016/s0002-8703(07)80043-3</Citation></Reference><Reference><Citation>Antzelevitch C, Brugada P, Borggrefe M, et&#xa0;al. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation. 2005;111(5):659-670. doi:10.1161/01.CIR.0000152479.54298.51</Citation></Reference><Reference><Citation>Marsman EMJ, Postema PG, Remme CA. Brugada syndrome: update and future perspectives. Heart. 2022;108(9):668-675. doi:10.1136/heartjnl-2020-318258</Citation></Reference><Reference><Citation>Steinmetz K, Rudic B, Borggrefe M, et&#xa0;al. J wave syndromes in patients with spinal and bulbar muscular atrophy. J Neurol. 2022;269(7):3690-3699. doi:10.1007/s00415-022-10992-5</Citation></Reference><Reference><Citation>Rosenbohm A, Hirsch S, Volk AE, et&#xa0;al. The metabolic and endocrine characteristics in spinal and bulbar muscular atrophy. J Neurol. 2018;265(5):1026-1036. doi:10.1007/s00415-018-8790-2</Citation></Reference><Reference><Citation>Shimizu W, Matsuo K, Kokubo Y, et&#xa0;al. Sex hormone and gender difference-role of testosterone on male predominance in Brugada syndrome. J Cardiovasc Electrophysiol. 2007;18(4):415-421. doi:10.1111/j.1540-8167.2006.00743.x</Citation></Reference><Reference><Citation>McKenna WJ, Judge DP. Epidemiology of the inherited cardiomyopathies. Nat Rev Cardiol. 2021;18(1):22-36. doi:10.1038/s41569-020-0428-2</Citation></Reference><Reference><Citation>Ommen SR, Semsarian C. Hypertrophic cardiomyopathy: a practical approach to guideline directed management. Lancet. 2021;398(10316):2102-2108. doi:10.1016/S0140-6736(21)01205-8</Citation></Reference><Reference><Citation>Gigli M, Begay RL, Morea G, et&#xa0;al. A review of the giant protein titin in clinical molecular diagnostics of cardiomyopathies. Front Cardiovasc Med. 2016;3(21). doi:10.3389/fcvm.2016.00021</Citation></Reference><Reference><Citation>Hattori T, Ikeda S, Yoshida K, et&#xa0;al. A patient with Kennedy-Alter-Sung syndrome showing cardiomyopathy. Rinsho Shinkeigaku. 1995;35(11):1246-1249.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>